Workflow
LIFEMD(LFMDP) - 2025 Q2 - Quarterly Report
2025-08-05 20:46
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from _________ to _________ Commission file number: 001-39785 LIFEMD, INC. (Exact name of registrant as specified in its charter) Delaware 76-0238453 (State or other Jurisdict ...
LifeMD(LFMD) - 2025 Q2 - Quarterly Report
2025-08-05 20:46
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2025 (866) 351-5907 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from _________ to _________ Commission file number: 001-39785 LIFEMD, INC. (Exact name of registrant as specified in its charter) Delaware 76-0238453 (State or oth ...
Generac (GNRC) - 2025 Q2 - Quarterly Report
2025-08-05 20:46
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 S45 W29290 Hwy 59, Waukesha, WI 53189 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34627 GENERAC HOLDINGS INC. (Exact name of registrant as specified in its charter) (St ...
Atomera(ATOM) - 2025 Q2 - Quarterly Results
2025-08-05 20:45
Exhibit 99.1 Management Commentary "As we continue to expand our ecosystem of industry partners and bring exciting new technology to the industry, we are seeing growing interest from potential customers," said Scott Bibaud, President and CEO. "Right now, Atomera is in a period of heavy customer wafer run activity across multiple technologies that we are confident will lead us to future commercial agreements." Financial Results The Company incurred a net loss of ($5.0) million, or ($0.17) per basic and dilut ...
Amentum Holdings, Inc.(AMTM) - 2025 Q3 - Quarterly Results
2025-08-05 20:45
Exhibit 99.1 Amentum Reports Third Quarter Fiscal Year 2025 Results and Raises Full Year Organic Guidance Revenues of $3.6 billion, 2% growth on a pro forma basis Net Income of $10 million; Adjusted EBITDA of $274 million Diluted Earnings Per Share of $0.04; Adjusted Diluted Earnings Per Share of $0.56 Operating Cash Flow of $106 million; Free Cash Flow of $100 million Backlog of $44.6 billion; 1.0x YTD Book-to-Bill Reduced Net Debt to $3.8 billion and Net Leverage to 3.5x CHANTILLY, VA., August 5, 2025 — A ...
Acadia Healthcare(ACHC) - 2025 Q2 - Quarterly Report
2025-08-05 20:45
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-35331 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) (State or ...
Granite Point Mortgage Trust(GPMT) - 2025 Q2 - Quarterly Results
2025-08-05 20:45
Granite Point Mortgage Trust Inc. Reports Second Quarter 2025 Financial Results and Post Quarter-End Update NEW YORK, August 5, 2025 – Granite Point Mortgage Trust Inc. (NYSE: GPMT) ("GPMT," "Granite Point" or the "Company") today announced its financial results for the quarter ended June 30, 2025, and provided an update on its activities subsequent to quarter-end. An earnings supplemental containing second quarter 2025 financial results can be viewed at www.gpmtreit.com. "We continued our progress in resol ...
Ingevity(NGVT) - 2025 Q2 - Quarterly Report
2025-08-05 20:45
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the quarterly period ended June 30, 2025 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 _______________________ ...
SLR Investment (SLRC) - 2025 Q2 - Quarterly Results
2025-08-05 20:45
EXHIBIT 99.1 FINANCIAL HIGHLIGHTS FOR THE QUARTER ENDED JUNE 30, 2025: At June 30, 2025: Investment Portfolio fair value: $2.1 billion | Comprehensive Investment Portfolio fair value: $3.2 billion Non-accruals: 0.3% at fair value, 0.5% at cost of Investment Portfolio Net assets: $992.3 million or $18.19 per share Leverage: 1.17x net debt-to-equity SLR Investment Corp. Announces Quarter Ended June 30, 2025 Financial Results Net Investment Income of $0.40 Per Share for Q2 2025; Stable NAV/Strong Credit Qualit ...
Arch Capital .(ACGL) - 2025 Q2 - Quarterly Report
2025-08-05 20:45
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-16209 ARCH CAPITAL GROUP LTD. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identifi ...